Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal ...

Calidi Biotherapeutics ( ($CLDI) ) has shared an announcement. Calidi Biotherapeutics, a biotechnology company specializing in targeted antitumor ...

Bacteria-based therapies represent an exciting breakthrough in cancer treatment, harnessing their remarkable ability to specifically target and attack tumors. To fully harness the potential of this ...

The lab of one University of Illinois researcher is receiving a hefty grant, which will be used towards cancer research. On ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that the staff of ...

A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the ...

Aura Biosciences has been able to advance its pipeline with great clinical success recently. Click here to read an analysis ...

T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid ...

Rebecca A. Shatsky, MD, discussed the I-SPY2.2 trial, its novel design, and its implications for the treatment of patients ...